Table 3.
Name | HBV/HCV Inhibition Target | Inhibition Activity | Ref. |
---|---|---|---|
Caffeic acid | HCV-1 infected Huh7.5.1 cells | IC50 inhibition: 100 ± 20 µM | [132] |
EHMT2 | Docking energy: −5.9 kcal/mol | [121] | |
HBV-DNA | IC50 inhibition: 3.9 ± 1.1 µM | [133] | |
HBsAg in vitro assay in infected HepG2.2.2.15 cells | IC50 inhibition: 12.7 ± 9.9 µM | [133] | |
HBeAg in vitro assay in infected HepG2.2.2.15 cells | IC50 inhibition: 109.3 ± 56.0 µM | [133] | |
Ferulic acid | No data | ||
Chlorogenic acid | EHMT2 | Docking energy: −7.8 kcal/mol | [121] |
STAT3 | Docking energy: −7.2 kcal/mol | [121] | |
HBV-DNA | IC50 inhibition: 1.2 ± 0.4 µM | [133] | |
HBsAg in vitro assay in infected HepG2.2.2.15 cells | IC50 inhibition: 241.5 ± 198.2 µM | [133] | |
HBeAg in vitro assay in infected HepG2.2.2.15 cells | IC50 inhibition: >1000 µM | [133] | |
Apigenin | EC50 of HBsAg | EC50 inhibition: 26.3 ± 5.6 µM | [134] |
EC50 of HBeAg | EC50 inhibition: 47.4 ± 3.3 µM | [134] | |
Kaempferol | HBV-RT | Docking energy: −9.0 kcal/mol | [66] |
HBcAg | Docking energy: −9.1 kcal/mol | [66] | |
Quercetin | HBV-RT | Docking energy: −8.3 kcal/mol | [66] |
HBcAg | Docking energy: −8.7 kcal/mol | [66] | |
NTCP | Docking energy: −5.4 kcal/mol | [66] | |
HBsAg in vitro assay in infected HepG2.2.2.15 cells | 60% inhibition | [66] | |
HBeAg in vitro assay in infected HepG2.2.2.15 cells | 62% inhibition | [66] | |
Isorhamnetin | No data | ||
Myricetin | Infected fulminant hepatitis mice | 66% increased survival rate | [113] |
Isoquercitrin | No data | ||
Myricitrin | HBV-RT | Docking energy: −7.7 kcal/mol | [66] |
HBcAg | Docking energy: −7.1 kcal/mol | [66] | |
NTCP | Docking energy: −6.7 kcal/mol | [66] | |
HBsAg in vitro assay in infected HepG2.2.2.15 cells | 44% inhibition | [66] | |
HBeAg in vitro assay in infected HepG2.2.2.15 cells | 35% inhibition | [66] |
IC50: Half maximal inhibitory concentration, EC50: Half maximal effective concentration, EHMT2: Euchromatic histone-lysine N-methyltransferase 2, HBsAg: Hepatitis B surface antigen, HBeAg: Hepatitis B e antigen, STAT3: Signal Transducer and Activator of Transcription 3, RT: Reverse transcriptase, NTCP: Sodium Taurocholate Cotransporting Polypeptide.